CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

News Releases

News Releases

CV Sciences, Inc.’s CEO Releases Letter to Stockholders and Customers Regarding Complaint filed by Securities and Exchange Commission

LAS VEGAS, NV–(Marketwired – June 19, 2017) – CV Sciences, Inc. (OTCQB: CVSI), (the “Company,” “CV Sciences,” “our” or “we”), today released a letter from Michael Mona, Jr., Chief Executive Officer, to stockholders and customers regarding a recent complaint filed by the Securities and Exchange Commission (the “SEC”): “Dear Stockholders and Customers, First, thank you … Continue reading CV Sciences, Inc.’s CEO Releases Letter to Stockholders and Customers Regarding Complaint filed by Securities and Exchange Commission

CV Sciences, Inc. Announces Commencement of IND Preparation Immediately Following Pre-IND Meeting with FDA

LAS VEGAS, NV – (Marketwired – June 19, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), today announced that it held its pre-IND meeting with the U.S. Food and Drug Administration (FDA) on June 15, 2017, to review its drug development plan for CVSI-007, the Company’s patent-pending product for … Continue reading CV Sciences, Inc. Announces Commencement of IND Preparation Immediately Following Pre-IND Meeting with FDA

CV Sciences, Inc. to Webcast Live at VirtualInvestorConferences.com June 1, 2017

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com LAS VEGAS, NV – May 30, 2017 /PRNewswire/ — CV Sciences, Inc. (OTCQB: CVSI), today announced that Chief Financial Officer, Joseph Dowling, will present live at VirtualInvestorConferences.com on June 1, 2017. DATE: Thursday,  June 1, 2017 TIME: 11:30 AM EDT LINK: https://tinyurl.com/0601prepr … Continue reading CV Sciences, Inc. to Webcast Live at VirtualInvestorConferences.com June 1, 2017

CV Sciences, Inc. to Present at the 7th Annual LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / May 23, 2017 / CV Sciences, Inc. (OTCQB: CVSI (the “Company,” “CV Sciences, “our,” or “we”) today announced that it will be presenting at the 7th annual LD Micro Invitational on Tuesday, June 6, at 1:00 PM PST / 4:00 PM EST. Joseph Dowling, Chief Financial Officer of CV Sciences, Inc., … Continue reading CV Sciences, Inc. to Present at the 7th Annual LD Micro Invitational

CV Sciences, Inc. Appoints Dr. Stephen M. Schmitz to its Board of Directors

Highly Regarded Pharma Veteran with Extensive Expertise in Drug Safety, Dietary Supplement Safety, Clinical Development and Regulatory Affairs LAS VEGAS, NV – (Marketwired – May 16, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (“CV Sciences,” “our” or “we”), today announced the appointment of Stephen M. Schmitz, MD, MPH to its Board of Directors effective May … Continue reading CV Sciences, Inc. Appoints Dr. Stephen M. Schmitz to its Board of Directors

CV Sciences, Inc. Highlights WHO’s World No Tobacco Day – May 31, 2017

LAS VEGAS, NV – (Marketwired – May 8, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), is pleased to highlight the World Health Organization (WHO) and its partners in the annual World No Tobacco Day on May 31, 2017. The day notably features the health and risks associated with … Continue reading CV Sciences, Inc. Highlights WHO’s World No Tobacco Day – May 31, 2017

CV Sciences, Inc. Launches First Online Education Platform for Retail Sales Associates and Industry Professionals

Company expands hemp-derived CBD education efforts and builds expertise and brand advocacy amongst its growing number of wholesale and retailer partners   LAS VEGAS, NV–(Marketwired – March 13, 2017) – CV Sciences, Inc., (OTCBB: CVSI) preeminent supplier and manufacturer of hemp-derived CBD oil bulk and consumer products, today announced the launch of the first online … Continue reading CV Sciences, Inc. Launches First Online Education Platform for Retail Sales Associates and Industry Professionals

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil™, at Natural Products Expo West in Anaheim, CA – March 9-12, 2017

Company will be launching new products, hosting an interactive presentation, providing retailer education, and offering giveaways and show specials to natural health retailers attending the show LAS VEGAS, NV–(Marketwired – February 28, 2017) – CV Sciences, Inc. (OTCBB: CVSI), leading supplier and manufacturer of hemp-derived CBD oil, announces that its industry dominating brand of hemp-derived … Continue reading CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil™, at Natural Products Expo West in Anaheim, CA – March 9-12, 2017

CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference

LAS VEGAS, NV–(Marketwired – January 25, 2017) – CV Sciences, Inc. (OTCBB: CVSI) (the “Company”), announced today that it will be presenting at the NobleCon13 Annual Investor Conference to be held January 30-31, 2017 at the Boca Raton Resort & Club, Florida. Event: NobleCon13 Annual Investor Conference Location: Boca Raton Resort & Club – Boca … Continue reading CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference